Sharemaestro Newsreel

Medline Earnings: Solid Sales Momentum Overshadowed by Margin Concerns, but Selloff Overblown

Medline reported strong revenue and adjusted EBITDA growth of 12% and 13% respectively in the second quarter. Despite raising organic sales growth outlook, the adjusted EBITDA margin outlook was lowered, leading to a 13% drop in shares. The author suggests the selloff might be …

LeMaitre Vascular, Inc. Stock 12‑Month Price Target Cut to $116.25, Implies 10% Upside

LeMaitre Vascular, Inc.'s average 12-month price target has been lowered from $118.75 to $116.25 by 8 analysts, suggesting a 10% upside from its Aug. 4 closing price. The consensus rating remains a "Buy" from 9 analysts, with 5 recommending Buy and 4 recommending Hold.

Envista Holdings Corp (NVST) (Q2 2026) Earnings Call Highlights: Strong Core Growth and Raised ...

Envista Holdings Corp (NVST) reported strong Q2 2026 results, with core sales up 5%, adjusted EBITDA increasing 28%, and adjusted EPS growing 58%. The company raised its full-year 2026 guidance due to broad-based growth across segments and geographies. However, anticipated headwinds include a Q4 …

Kestra Medical Technologies CCO Ford sells $151,140 in stock

Kestra Medical Technologies' Chief Commercial Officer, Alfred J. Ford Jr., sold 6,275 common shares totaling $151,140 on August 4, 2026. This transaction was non-discretionary, intended to cover tax withholding obligations from restricted stock unit vesting. Following the sale, Mr. Ford Jr. still beneficially owns …

Solventum (NYSE: SOLV) to separate $1.4B Health Information Systems arm

Solventum (NYSE: SOLV) announced its intention to separate its Health Information Systems (HIS) business, which generated $1.4 billion in net sales in 2025. This move is part of a broader portfolio optimization strategy to transform Solventum into a more focused MedTech company. The company …

Align Technology (NASDAQ: ALGN) balances VAT hit with $200M India plant plan

Align Technology reported Q2 2026 net revenues of $1,056.2 million, up 4.3% year-over-year, driven by strong Clear Aligner revenues. The company also announced plans to invest $200 million in a new manufacturing facility in Hyderabad, India, expected to commence operations in 2027. This expansion …

Embecta Corp. (EMBC): Deeply Undervalued Global Medical Device Company

Embecta Corp. (EMBC), a global medical device company specializing in diabetes care, is highlighted as a potentially undervalued opportunity. Despite operating in a defensive healthcare sector with stable demand, EMBC trades at attractive valuation levels, boasting strong cash generation, resilient profitability, and an improving …

Envista Holdings Corporation 2026 Q2 - Results - Earnings Call Presentation (NYSE:NVST) 2026-08-05

Azenta (AZTA) Stock Rallies on Revenue Strength as Cash Burn Lingers

FEMY Q2'26 Earnings: revenue estimate is 730.67K USD

Femasys Inc. (FEMY) is scheduled to announce its Q2'26 earnings on August 12, 2026. The company is projected to report an estimated revenue of 730.67 thousand USD and an EPS of (1.27) USD for the quarter. The article provides a detailed table of past …

Earnings call transcript: KORU Medical beats Q2 2026 estimates, shares fall

KORU Medical Systems reported better-than-expected earnings and revenue for Q2 2026, with adjusted EPS of $0.02 and revenue of $12.0 million. Despite the beat, shares fell after hours due to reduced full-year revenue guidance and slower international expansion. The company achieved positive net income …

Earnings call transcript: Nyxoah posts strong Q2 2026 growth as stock slips

Nyxoah reported strong Q2 2026 results with worldwide revenue growing 21% sequentially to €7.7 million, driven by accelerated U.S. commercialization where active accounts doubled and prior authorizations increased by 77%. The company strengthened its balance sheet with $110 million in financing and maintained its …

Earnings call transcript: OraSure tops Q2 2026 revenue forecast, shares jump

OraSure Technologies exceeded its Q2 2026 revenue forecast, reporting $30.6 million against an expected $28.83 million, leading to a 6.92% jump in after-hours trading. The company highlighted improving gross margins, new product clearances like Colli-Pee Dx and OraQuick Ebola 2.0, and a strong balance …

Bionano Genomics (BNGO) grants 5,000 options to officer

Bionano Genomics (BNGO) reported that its Principal Accounting Officer, Mark Adamchak, received a grant of 5,000 stock options. These options have an exercise price of $1.12 per share, vest 50% on the first and second anniversaries of the vesting commencement date, and expire on …

Bionano Genomics (NASDAQ: BNGO) awards 15,000 options to its general counsel

Bionano Genomics (NASDAQ: BNGO) has granted 15,000 stock options to its General Counsel, Jonathan V. Dixon, on August 3, 2026. The options have an exercise price of $1.12 per share and will expire on August 2, 2036. These options vest 50% on each of …

Bionano Genomics, Inc. (BNGO) CSO lists 54,000-share stock option position

Bionano Genomics, Inc. (BNGO) Chief Scientific Officer Hastie Alex Reid has reported a stock option to buy 54,000 shares of common stock at an exercise price of $1.12 per share, expiring on August 2, 2036. The vesting schedule includes 25% of the shares becoming …

ALIGN TECHNOLOGY INC 2026: Revenue $1.06B, EPS $1.51— 10-Q Summary

ALIGN TECHNOLOGY INC (ALGN) reported its 2026 quarterly results with a revenue of $1.06 billion, an increase of 4.3% year over year, despite a decline in net income and diluted EPS. The company's Clear Aligner revenues saw an 8.2% rise, driven by higher case …

OraSure Technologies (NASDAQ:OSUR) Releases Earnings Results, Beats Estimates By $0.07 EPS

Activist pressure pushes Eagan-based Solventum to divest billion-dollar business

Eagan-based Solventum, a 3M spinoff, plans to divest its Health Information Systems (HIS) unit, which generates $1.4 billion in annual sales. This move comes after sustained pressure from activist investor Trian Fund Management, one of Solventum's largest shareholders, to streamline the company's focus. The …

A Look at ICU Medical Inc (ICUI) After 3.3% Decline -- GF Value $120.31 vs Price $166.40

ICU Medical Inc (ICUI) experienced a 3.3% share decline, bringing its price to $166.40, while its GF Value is estimated at $120.31, suggesting the stock is 38.3% overvalued. Despite a strong GF Score of 80/100, indicating solid fundamentals, both its financial strength and valuation …

Merit Medical to Participate in Upcoming Investors Conferences in August

Merit Medical Systems, Inc. announced its participation in two investor conferences in August 2026. Management will hold fireside chats at the Canaccord Genuity 46th Annual Growth Conference and the Bank of America SMID Cap Conference. Live audio webcasts and replays will be available on …

AtriCure, Inc. SEC Filing (Aug 5, 2026)

This article reports on an SEC Form 144 filing by AtriCure, Inc. (ATRC) on August 5, 2026. The filing indicates a proposed sale of 3,500 common shares acquired through restricted stock, with an aggregate market value of $134,467.90, to be sold via Morgan Stanley …

KORU Medical Systems, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:KRMD) 2026-08-05

KORU Medical Systems, Inc. (KRMD) published a slide deck in conjunction with their Q2 2026 earnings call. This presentation provides details related to their financial results for the second quarter of 2026. The article was written by SA Transcripts, which is responsible for publishing …

Nephros to File Q2 Results After Close, Host 4:30 ET Call

Nephros (Nasdaq: NEPH) announced it will file its second-quarter 2026 financial results after market close on Thursday, August 06, 2026. The company will host a conference call on the same day at 4:30 p.m. ET. Dial-in details for domestic and international participants, along with …

Is STAAR Surgical (STAA) Undervalued After Naming A New CEO?

STAAR Surgical (STAA) recently appointed Warren Foust as its new CEO, drawing investor attention despite recent share price declines. While analysts set a consensus price target of $29.67, indicating the stock is undervalued, key risks such as reliance on a single distributor in China …

OraSure earnings beat, revenue topped estimates

Bilal Muhsin, Connected Care Segment, Becton Dickinson

Bilal Muhsin, Executive Vice President and President of the Connected Care Segment at Becton Dickinson (BD), discusses the evolution of connected care in hospitals, moving from episodic data to real-time, predictive insights. He highlights how BD's integrated platforms, like BD Incada, enable smarter alert …

Solventum beats estimates, raises guidance on strong growth

Solventum Corp (NYSE:SOLV) exceeded analyst expectations in its second-quarter results and raised its full-year guidance, driven by strong organic sales growth across all business segments. The medical technology company posted adjusted EPS of $2.55, beating estimates by $1.04, and reported revenue of $2.2 billion. …

Medline's Customer Expansion Continues to Impress but Margin Looks Challenged

Medline, the largest provider of medical-surgical products in the US, continues to expand its customer base and maintain high retention rates with prime vendor relationships, which account for over 60% of its revenue. Despite solid sales momentum and a strategy to increase brand penetration …

Baxter International Announces Upcoming CFO Leadership Transition

Baxter International announced that Anita Zielinski will resign as Interim CFO and Senior Vice President, Chief Accounting Officer and Controller, effective September 15, 2026, to join another company. The company clarified that her departure is not due to any disagreements regarding operations or financial …

Solventum Q2 2026 Earnings: 9.5% Organic Growth Supports Higher Guidance

Solventum reported strong Q2 2026 results with 9.5% organic sales growth and a 50.9% increase in adjusted diluted EPS, prompting the company to raise its full-year guidance. While all segments showed growth and expanded margins, GAAP operating margin was impacted by significant legal, separation, …

LeMaitre Vascular stock hits 52-week low at 79.38 USD

LeMaitre Vascular (LMAT) stock recently hit a 52-week low at $79.38, despite having a strong 1-year return of nearly 25% and being up over 31% year-to-date. The medical device maker is trading below its Fair Value estimate, with analysts setting price targets between $100 …

OraSure Q2 2026 Earnings: A $22.6 Million Remeasurement Drove GAAP Profit

OraSure Technologies reported Q2 2026 net revenue of $30.6 million, a 2% decrease year-over-year, but achieved GAAP profitability with diluted EPS of $0.09, up from a loss of $0.26. This GAAP profit was primarily due to a $22.6 million reduction in acquisition-related contingent consideration, …

Azenta Inc (AZTA) (Q3 2026) Earnings Call Highlights: Organic Growth Surges 9% Amid Strategic ...

Mount Logan Capital sets Aug. 12 call to discuss Q2 results

Mount Logan Capital Inc. (Nasdaq: MLCI) announced it will release its second quarter 2026 financial results after market close on Tuesday, August 11, 2026. The company will host a conference call on Wednesday, August 12, 2026, at 10:00 a.m. Eastern Time to discuss these …

Solventum (NYSE: SOLV) raises 2026 guidance on strong Q2 earnings jump

Solventum (NYSE: SOLV) reported strong second-quarter 2026 results, with net sales of $2.2 billion and a 50.9% increase in adjusted diluted EPS to $2.55. The company also announced its intent to separate its Health Information Systems segment to focus on MedTech and raised its …